Pharmaceutical Industry Information Portal

HomeTagsBristol Myers Squibb

All posts by tag

Bristol Myers Squibb

U.S FDA approves expanded use of Bristol Myers lung cancer medication

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Opdivo®(nivolumab) in combination with platinum-doublet chemotherapy for adult patients with resectable...

Eisai and BMS Enter Into Strategic Collaboration for MORAb-202 Antibody Drug Conjugate

Bristol Myers Squibb will pay $650 million U.S. dollars to Eisai including $200 million U.S. dollars as payment toward Eisai research and development expenses.

Expert Articles